Kwong Lung Enterprise Co Ltd (TWO:8916) — Stock Price
Kwong Lung Enterprise Co Ltd (TWO:8916) is currently trading at NT$43.25 TWD, up 0.82% today. Over the past 52 weeks, shares have ranged between NT$41.75 and NT$50.60. This page tracks Kwong Lung Enterprise Co Ltd's live share price on the TWO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Kwong Lung Enterprise Co Ltd worth.
Kwong Lung Enterprise Co Ltd (8916) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Kwong Lung Enterprise Co Ltd's daily closing share price and trading volume on the TWO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Kwong Lung Enterprise Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Kwong Lung Enterprise Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | NT$7.89 Billion | NT$7.71 Billion | NT$10.30 Billion | NT$8.06 Billion | NT$8.50 Billion |
| Cost of Revenue | NT$6.53 Billion | NT$6.40 Billion | NT$8.61 Billion | NT$7.14 Billion | NT$7.40 Billion |
| Gross Profit | NT$1.37 Billion | NT$1.31 Billion | NT$1.69 Billion | NT$920.93 Million | NT$1.10 Billion |
| Research & Development | NT$50.98 Million | NT$53.07 Million | NT$50.91 Million | NT$48.82 Million | NT$53.65 Million |
| SG&A | NT$727.08 Million | NT$367.02 Million | NT$357.40 Million | NT$313.47 Million | NT$295.71 Million |
| Total Operating Expenses | NT$7.31 Billion | NT$713.83 Million | NT$739.25 Million | NT$733.06 Million | NT$718.64 Million |
| Operating Income | NT$587.33 Million | NT$597.23 Million | NT$953.71 Million | NT$187.87 Million | NT$380.37 Million |
| EBITDA | — | NT$753.79 Million | NT$1.13 Billion | NT$367.75 Million | NT$579.61 Million |
| EBIT | — | NT$597.23 Million | NT$953.71 Million | NT$187.87 Million | NT$380.37 Million |
| Interest Expense | NT$35.57 Million | NT$25.34 Million | NT$20.96 Million | NT$13.92 Million | NT$14.19 Million |
| Income Before Tax | NT$741.78 Million | NT$723.36 Million | NT$1.11 Billion | NT$492.44 Million | NT$405.62 Million |
| Income Tax Expense | — | NT$169.27 Million | NT$213.60 Million | NT$121.43 Million | NT$103.21 Million |
| Net Income | NT$609.29 Million | NT$577.70 Million | NT$919.08 Million | NT$515.29 Million | NT$344.41 Million |
Kwong Lung Enterprise Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Kwong Lung Enterprise Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | NT$10.28 Billion | NT$7.98 Billion | NT$8.57 Billion | NT$8.29 Billion | NT$7.51 Billion |
| Total Current Assets | NT$4.91 Billion | NT$4.02 Billion | NT$5.16 Billion | NT$5.33 Billion | NT$4.46 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$446.98 Million | NT$566.61 Million | NT$62.87 Million | NT$85.67 Million | NT$174.36 Million |
| Net Receivables | NT$757.31 Million | NT$863.16 Million | NT$1.30 Billion | NT$1.41 Billion | NT$1.37 Billion |
| Inventory | NT$2.45 Billion | NT$1.64 Billion | NT$2.12 Billion | NT$2.40 Billion | NT$1.72 Billion |
| Property, Plant & Equipment | — | — | NT$1.73 Billion | NT$1.68 Billion | NT$2.02 Billion |
| Goodwill | — | NT$22.02 Million | NT$22.02 Million | NT$22.02 Million | NT$22.02 Million |
| Total Liabilities | NT$4.30 Billion | NT$2.38 Billion | NT$2.99 Billion | NT$3.31 Billion | NT$2.57 Billion |
| Total Current Liabilities | NT$3.35 Billion | NT$1.72 Billion | NT$2.40 Billion | NT$2.50 Billion | NT$2.34 Billion |
| Long-term Debt | NT$731.36 Million | NT$485.00 Million | NT$427.21 Million | NT$640.82 Million | NT$13.04 Million |
| Net Debt | NT$1.70 Billion | NT$159.98 Million | NT$-207.44 Million | NT$462.61 Million | NT$174.79 Million |
| Total Stockholder Equity | NT$5.83 Billion | NT$5.60 Billion | NT$5.57 Billion | NT$4.96 Billion | NT$4.92 Billion |
| Retained Earnings | NT$1.23 Billion | NT$1.19 Billion | NT$1.18 Billion | NT$872.77 Million | NT$630.95 Million |
Kwong Lung Enterprise Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Kwong Lung Enterprise Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$106.39 Million | NT$1.29 Billion | NT$1.60 Billion | NT$-507.72 Million | NT$1.24 Billion |
| Capital Expenditures | NT$358.12 Million | NT$312.37 Million | NT$277.40 Million | NT$333.16 Million | NT$499.73 Million |
| Free Cash Flow | NT$-251.73 Million | NT$975.97 Million | NT$1.32 Billion | NT$-840.88 Million | NT$739.85 Million |
| Investing Cash Flow | — | — | NT$-562.95 Million | NT$682.16 Million | NT$-477.19 Million |
| Financing Cash Flow | — | NT$-766.51 Million | NT$-943.74 Million | NT$100.05 Million | NT$-495.71 Million |
| Dividends Paid | NT$-541.58 Million | NT$569.32 Million | NT$439.95 Million | NT$439.09 Million | NT$437.52 Million |
| Stock-Based Compensation | NT$4.21 Million | NT$5.10 Million | NT$2.46 Million | NT$2.88 Million | NT$5.33 Million |
| Depreciation | NT$157.28 Million | NT$156.56 Million | NT$177.51 Million | NT$179.88 Million | NT$199.24 Million |
| Change in Cash | NT$-294.00 Million | NT$-617.88 Million | NT$180.21 Million | NT$290.62 Million | NT$183.69 Million |
Kwong Lung Enterprise Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Kwong Lung Enterprise Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | — | — | — |
| Mar 09, 2026 | — | — | — |
| Nov 07, 2025 | 1.40 | 1.23 | +13.82% |
| Aug 11, 2025 | 0.67 | 0.54 | +24.07% |
| May 07, 2025 | — | — | — |
| Mar 17, 2025 | 0.50 | 0.48 | +4.17% |
| Nov 06, 2024 | 0.91 | 1.22 | -25.41% |
| Aug 07, 2024 | 1.62 | 1.52 | +6.58% |